Market Statistics
Study Period | 2019 - 2030 |
2024 Market Size | USD 320.9 Million |
2030 Forecast | USD 507.1 Million |
Growth Rate (CAGR) | 7.9% |
Largest Region | North America |
Fastest Growing Region | Asia-Pacific |
Nature of the Market | Fragmented |
Report Code: 12508
Get a Comprehensive Overview of the Biological Safety Cabinet Market Report Prepared by P&S Intelligence, Segmented by Type (Class I, Class II, Class III), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Laboratories), Application (Industrial, R&D, Academic), and Geographic Regions. This Report Provides Insights From 2019 to 2030.
Study Period | 2019 - 2030 |
2024 Market Size | USD 320.9 Million |
2030 Forecast | USD 507.1 Million |
Growth Rate (CAGR) | 7.9% |
Largest Region | North America |
Fastest Growing Region | Asia-Pacific |
Nature of the Market | Fragmented |
Explore the market potential with our data-driven report
The global biological safety cabinet market generated revenue of USD 320.9 million in 2024, which is expected to witness a CAGR of 7.9% during 2024–2030, to reach USD 507.1 million by 2030. This can be ascribed to the rise in research and development activities in the fields of pharmaceuticals, biotechnology, and life sciences, to find safe and effective drugs. Moreover, the quick progress in the creation of infectious illness vaccines and the growth in the prevalence of chronic diseases drive the market growth.
R&D spending has risen significantly in recent years, which has resulted in an increase in the number of labs being established, thereby driving the need for biosafety cabinets. Currently, 4 out of every 10 drugs in the development phase are biologics, as a result of the rising need for orphan drugs and customized medications.
Moreover, an evolution in the regulatory guidelines for guaranteeing appropriate biosafety for the people working in laboratories has been brought on by the SARS-CoV-2 epidemic. For instance, according to the Centers for Disease Control and Prevention, clinical laboratories must handle patient samples, such as urine, blood (and blood components), and respiratory specimens, while following strict precautions. The World Health Organization and other regulators are expected to issue more laboratory biosafety recommendations in the future, which will lead to a surge in the demand for these cabinets worldwide.
This market is categorized into class I, class II, and class III. Among these, the class II category accounted for the largest revenue share, around 50%, in 2022, and it is further expected to maintain its dominance during the forthcoming period. This is owing to the high adoption of class II biosafety cabinets because they provide strong protection to the sample, as well as the user and the surrounding environment. These variants are essentially used to protect those carrying out microbiological work or sterile pharmacy compounding.
In addition, the class I category will show significant growth during the coming period. This is because these variants are used as a ventilated unit for personnel and environment protection in an effective and budget-friendly way. These alternatives are suited to basic procedures, such as those carried out in a small R&D facility without much complex equipment.
Based on end user, the pharmaceutical and biotechnology companies category held the largest revenue share, around 70%, in 2022, and it is further expected to maintain its dominance during the forecast period. This is attributed to the rising demand for biologics and the fact that microbial contamination of pharmaceutical drugs leads to a negative impact on patients health, with the potential to significantly raise the risk of long-term morbidity and even mortality. Thus, pharmaceutical and biotechnology companies need to manufacture safe and effective drugs, for which these cabinets are vital.
Moreover, this sector depends on a robust R&D ecosystem, which, in turn, depends on advanced technologies to reduce contamination in the sample and personnel.
Furthermore, the academic and research institutes category has a significant growth potential during the forecast period, due to the increase in the R&D activities in all spectra of the healthcare sector. Moreover, almost all academic institutes, especially universities, have research facilities dedicated to medical devices, pharma and biologic drugs, and disease diagnosis. Moreover, with universities receiving substantial grants from governments for medical research, it has become imperative for them to have biosafety cabinets.
Drive strategic growth with comprehensive market analysis
Geographically, North America held the largest share, of around 45%, in 2022, and it is set to grow at a robust CAGR during the projection period, due to the substantial research and development activities in the pharmaceutical and biotechnology sectors, as well as the elevated risk of communicable diseases in this region. Other major drivers for product sales in the continent are the existence of well-known healthcare businesses, a solid vaccination and epidemiologic research foundation, and robust support for R&D initiatives. Additionally, the rapid uptake of new technologies and the increase cases of chronic diseases both support the expansion of the demand for such cleanroom equipment in the region.
Additionally, North America boasts advanced healthcare infrastructure and supportive government policies for the sale of healthcare-related goods, as well as for reimbursements for medical procedures. Moreover, companies in the region are focusing on the development of innovative products, to cater to the healthcare sector. For instance, Labconco introduced its upgraded Axiom biosafety cabinets in May 2021. Similarly, its updated Logic+ biosafety cabinets, featuring stronger safety protocols, ergonomic design, and an operating system, were revealed in May 2019.
Moreover, Europe will show significant growth for this market, with the advancement of the healthcare infrastructure and favorable policies for taking safety initiatives for their employees and the peoples. In addition, this region has built new R&D infrastructure for develop the growth of region which, in turn, could drive the market of biological safety cabinet market.
Asia-Pacific has been witnessing a rise in the prevalence of infectious diseases; thus, encouraging the demand for cleanroom technology solutions including biological safety cabinets in healthcare settings. In addition, the growing adoption of cleanroom solutions for the manufacturing and packing of biotechnology products is supporting the market growth in the region. Furthermore, the wide application of cleanroom technology in the manufacturing of sterile pharmaceuticals and medical devices is a key factor contributing to the market growth.
This report offers deep insights into the biological safety cabinet industry, with size estimation for 2019 to 2030, the major drivers, restraints, trends and opportunities, and competitor analysis.
Based on Type
Based on End User
Based on Application
Geographical Analysis
The market for biological safety cabinets was worth USD 320.9 million in 2024.
The biological safety cabinet industry is growing with the booming pharma and biopharma sector, rising healthcare research funding, and increasing patient count.
Class II variants sell the most in the market for biological safety cabinets.
The pharmaceutical and biotechnology companies category dominates the end user segment of the biological safety cabinet industry.
North America is the largest and APAC the fastest-growing market for biological safety cabinets.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
IndiaOur insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages